Althea Group Holdings (ASX:AGH) signed a deal to sell its MyAccess Clinics business in the UK and Ireland for AU$1 million to Montu Group UK, according to a Thursday filing with the Australian bourse.
Additionally, Montu will purchase Althea products at a minimum of 10,300 units on commercial terms in the UK for 24 months, the filing said. The medicinal and recreational cannabis firm's products will remain on the clinic's drugs list for three years after completion.
Shares of Althea Group closed up by more than 4% on Thursday and earlier hit a new 52-week high.
Price (AUD): $0.05, Change: $+0.002, Percent Change: +4.17%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments